Forma Therapeutics Holdings - Stock Price History | FMTX

Historical daily share price chart and data for Forma Therapeutics Holdings since 2021 adjusted for splits. The latest closing stock price for Forma Therapeutics Holdings as of September 23, 2021 is 23.73.
  • The all-time high Forma Therapeutics Holdings stock closing price was 51.08 on December 09, 2020.
  • The Forma Therapeutics Holdings 52-week high stock price is 56.33, which is 137.4% above the current share price.
  • The Forma Therapeutics Holdings 52-week low stock price is 21.04, which is 11.3% below the current share price.
  • The average Forma Therapeutics Holdings stock price for the last 52 weeks is 32.92.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Forma Therapeutics Holdings Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 42.0586 39.0000 51.0800 32.9500 34.9000 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.111B $0.101B
Forma Therapeutics Holdings Inc. is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of novel therapeutics with rare hematologic diseases and cancers. Forma Therapeutics Holdings Inc. is based in Watertown, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $133.660B 8.90
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.482B 21.14
Biohaven Pharmaceutical Holding (BHVN) United States $8.764B 0.00
Emergent Biosolutions (EBS) United States $2.892B 6.98
Arcus Biosciences (RCUS) United States $2.573B 0.00
Myovant Sciences (MYOV) United Kingdom $2.051B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.021B 0.00
Zymeworks (ZYME) Canada $1.443B 0.00
Ambrx Biopharma (AMAM) United States $0.527B 0.00
SQZ Biotechnologies (SQZ) United States $0.417B 0.00
Enzo Biochem (ENZ) United States $0.172B 50.71